Tumour-growth suppression in nude mice by a murine monoclonal antibody: Factors hampering successful therapy
- 10 May 1991
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (2) , 297-304
- https://doi.org/10.1002/ijc.2910480224
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cellsInternational Journal of Cancer, 1988
- Killing of human tumor cell lines by human monocytes and murine monoclonal antibodiesCellular Immunology, 1988
- Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.Proceedings of the National Academy of Sciences, 1986
- Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.Proceedings of the National Academy of Sciences, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- Europium as a label in time-resolved immunofluorometric assaysAnalytical Biochemistry, 1984
- Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.The Journal of Experimental Medicine, 1983
- IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.Proceedings of the National Academy of Sciences, 1982
- Regulation of IgG Antibody-dependent Cellular Cytotoxicity in Vitro by IgM Antibodies.Scandinavian Journal of Immunology, 1981
- Antibody production by hybridomasJournal of Immunological Methods, 1980